Latest stories on XERS
Xeris Biopharma price target raised to $16 from $12 at Leerink
The Fly61 · neutralanalyst
Xeris Biopharma hosts webinar on XP-8121 development program
The Fly56 · neutralproduct/pr
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral
Xeris Announces Details for XP-8121 Program Overview Webinar
StockTitan55 · neutralproduct/pr
Xeris Biopharma: A Commercial Stage Pharma That May Be A Slow-Burn Buy Opportunity
Seeking Alpha58 · neutralgeneral
Xeris Biopharma price target raised to $12 from $9 at Barclays
The Fly63 · neutralanalyst
Xeris (XERS) Q2 2026 Earnings Call Transcript
Yahoo Top73 · bullishearnings
Xeris (XERS) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Xeris Biopharma Q2 Earnings Call Highlights
Yahoo Top73 · bullishearnings
Xeris forecasts $385M-$390M 2026 revenue as Recorlev expands and XP-8121 phase III start targets year end
Seeking Alpha73 · bullishearnings
Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Xeris Biopharma Tightens 2026 Revenue Guidance as Recorlev Delivers 81% Growth and Key Patents Extend IP Horizon
MarketChameleon67 · bullishearnings
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral
Xeris Biopharma Reports Second Quarter 2026 Financial Results
StockTitan34 · bearishearnings
Xeris Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026
StockTitan50 · neutralgeneral
Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges
TipRanks63 · neutralgeneral
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral
These low-priced stocks are flashing overbought signals
Seeking Alpha48 · neutralgeneral
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | XERS Stock News
StockTitan50 · neutralgeneral
Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | XERS Stock News
StockTitan50 · neutralgeneral
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral